A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors

Gideon M. Blumenthal(Merck & Co., Inc., Rahway, NJ, USA (United States)), Phillip A. Dennis(AVEO Oncology (United States))
Oncotarget
September 6, 2014
Cited by 39


Related Papers